166 related articles for article (PubMed ID: 14533142)
21. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
22. A rapid improvement in obsessive-compulsive disorder with milnacipran in a patient with schizophrenia.
Hung S; Hung GC
J Clin Psychopharmacol; 2014 Oct; 34(5):653-4. PubMed ID: 25076421
[No Abstract] [Full Text] [Related]
23. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury.
Kanetani K; Kimura M; Endo S
J Nippon Med Sch; 2003 Aug; 70(4):313-20. PubMed ID: 12928711
[TBL] [Abstract][Full Text] [Related]
24. ACS chemical neuroscience molecule spotlight on savella.
Hopkins CR
ACS Chem Neurosci; 2010 May; 1(5):345. PubMed ID: 22778830
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region.
Ito M; Kimura H; Yoshida K; Kimura Y; Ozaki N; Kurita K
Clin Neuropharmacol; 2010; 33(2):79-83. PubMed ID: 20375656
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs and SSRIs: a modeling approach.
Dardennes R; Berdeaux G; Lafuma A; Fagnani F
Eur Psychiatry; 1999 Jun; 14(3):152-62. PubMed ID: 10572341
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of milnacipran in patients with fibromyalgia.
Gendreau RM; Thorn MD; Gendreau JF; Kranzler JD; Ribeiro S; Gracely RH; Williams DA; Mease PJ; McLean SA; Clauw DJ
J Rheumatol; 2005 Oct; 32(10):1975-85. PubMed ID: 16206355
[TBL] [Abstract][Full Text] [Related]
28. Milnacipran for chronic pain in the orofacial region.
Pae CU
Clin Neuropharmacol; 2010; 33(5):270. PubMed ID: 20864840
[No Abstract] [Full Text] [Related]
29. Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease.
Mizukami K; Hatanaka K; Tanaka Y; Sato S; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):349-52. PubMed ID: 19166899
[TBL] [Abstract][Full Text] [Related]
30. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of milnacipran and paroxetine in outpatients with major depression.
Sechter D; Vandel P; Weiller E; Pezous N; Cabanac F; Tournoux A;
J Affect Disord; 2004 Dec; 83(2-3):233-6. PubMed ID: 15555719
[TBL] [Abstract][Full Text] [Related]
32. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC
J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989
[TBL] [Abstract][Full Text] [Related]
33. Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment.
Sakakibara R; Ito T; Uchiyama T; Awa Y; Yamaguchi C; Hattori T
Urol Int; 2008; 81(3):335-9. PubMed ID: 18931554
[TBL] [Abstract][Full Text] [Related]
34. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB
Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646
[TBL] [Abstract][Full Text] [Related]
35. Japanese experience with dual-action antidepressants.
Tajima O
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-42. PubMed ID: 12369609
[TBL] [Abstract][Full Text] [Related]
36. Effects of milnacipran on cognitive flexibility following chronic stress in rats.
Naegeli KJ; O'Connor JA; Banerjee P; Morilak DA
Eur J Pharmacol; 2013 Mar; 703(1-3):62-6. PubMed ID: 23422875
[TBL] [Abstract][Full Text] [Related]
37. [Applications and safety of modern antidepressants in patients with liver diseases].
Dubarek W; Kucia K
Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
[TBL] [Abstract][Full Text] [Related]
38. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
Rénéric JP; Bouvard M; Stinus L
Behav Brain Res; 2002 Nov; 136(2):521-32. PubMed ID: 12429415
[TBL] [Abstract][Full Text] [Related]
39. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.
Yoshimura R; Mitoma M; Sugita A; Hori H; Okamoto T; Umene W; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1034-7. PubMed ID: 17459550
[TBL] [Abstract][Full Text] [Related]
40. The dubious effect of milnacipran for the treatment of burning mouth syndrome.
Sugimoto K
Clin Neuropharmacol; 2011; 34(4):170-3. PubMed ID: 21738026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
